Related Experiment Video
Updated: Aug 8, 2026

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
Characterization of a monoclonal antibody with CD44 like reactivity
G Kremmidiotis1, G Russ, R Starr
1Department of Clinical Immunology, Flinders Medical Centre, Flinders University of South Australia, Bedford Park.
Insights
Monoclonal antibody QE7.3E8 initially appeared to target CD18 but showed distinct staining patterns. Further experiments confirmed QE7.3E8 reacts with the CD44 antigen, not CD18.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Monoclonal antibodies are crucial tools in immunology for identifying cell surface antigens.
- QE7.3E8 is a monoclonal antibody with an observed immunoprecipitation pattern.
- Initial characterization suggested QE7.3E8 might be a CD18 antibody.
Purpose of the Study:
- To clarify the precise cell surface antigen recognized by the monoclonal antibody QE7.3E8.
- To differentiate QE7.3E8 from known CD18 and CD11 antibodies.
- To determine the expression profile and molecular interactions of the antigen targeted by QE7.3E8.
Main Methods:
- Immunoprecipitation assays using B cell lines, monocytes, and T cell lines.
- Tissue staining and distribution analysis.
- Cross-immunoprecipitation experiments.
- Sequential immunoprecipitation with QE7.3E8 and a known CD44 antibody (SBU 25-32).
Main Results:
- QE7.3E8 precipitated different band patterns from B cells (90, 160 kd) and monocytes (90, 130, 146, 160 kd).
- Tissue distribution of QE7.3E8 differed significantly from CD18 antibodies.
- QE7.3E8 precipitated four bands from T cells lacking CD11b/CD11c alpha chains, inconsistent with CD18.
- Cross-immunoprecipitation showed no association between QE7.3E8 and CD11a targets.
- Sequential precipitation experiments indicated QE7.3E8 reacts with CD44, consistent with its known high molecular weight complexes.
Conclusions:
- The monoclonal antibody QE7.3E8 does not recognize the CD18 antigen.
- QE7.3E8 specifically targets the CD44 antigen.
- The multiple bands observed in immunoprecipitation are likely due to CD44 complexes, not distinct molecules associated with CD18.
Abstract:
QE7.3E8 is a monoclonal antibody which precipitates two bands (90 and 160 kd) from a B cell line and four (90, 130, 146, and 160 kd) from monocytes. Whilst this immunoprecipitation pattern suggests that QE7.3E8 is a CD18 antibody, a number of other results are inconsistent with this interpretation. In particular, QE7.3E8 stains lymphoid tissue with a distribution clearly distinguishable from CD18 antibodies; it precipitates four bands from a T cell line which does not express the CD11b and CD11c alpha chains, and cross immunoprecipitation with QE7.3E8 and a CD11a antibody show that the molecules recognized by these antibodies are not associated. However, in tissue distribution and sequential precipitation experiments QE7.3E8 behaves like a CD44 antibody. CD44 identifies a single 85 kd protein, but high molecular weight complexes have been described, accounting for the multiple bands seen in immunoprecipitation studies. Sequential immunoprecipitation using QE7.3E8 and a Workshop-clustered monoclonal antibody (SBU 25-32) indicate that the QE7.3E8 reacts with the CD44 antigen.
More Related Videos
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.

